I costi dei pazienti con patologie infiammatorie dell’intestino (Malattia di Crohn e colite ulcerosa). Studio real world in Italia:

Global & Regional Health Technology Assessment

StefanoCapri¹ 

关键词: Biologics;    cost of illness;    Crohn’s disease;    inflammatory bowel disease;    Italy;    real-world study;    ulcerative colitis;   

DOI  :  10.1177/2284240318793281

学科分类：医学（综合）

来源: Sage Journals

【 摘 要 】

Introduction:Inflammatory bowel disease (IBD) is very disabling condition. Due to the chronic nature of IBDs, it is crucial to better understand the economic burden in a real-world setting.Methods:We conducted a retrospective descriptive study using the health information systems of the Agency for Health Protection of the Province of Milan (3.5 million inhabitants) for the period 2011-2015. Average cost per patient was calculated for each disease (ulcerative colitis and Crohn’s disease). Subgroup analyses were performed regarding patients treated with biologics.A generalized linear model controlling for patient age and Charlson co-morbidity index was used to calculate the adjusted mean costs. Regression analyses were based on dependent variables of individual costs.Results:A total of 12,720 IBD cases were studied, 7,981 of ulcerative colitis (UC) and 4,739 of Crohn’s disease (CD). The mean total cost of UC patients was €12,707 and €9,527 for CD patients (euro 2017). The mean total cost of UC patients trea...

【 授权许可】

CC BY